Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Diabetic Retinopathy; Macular Degeneration Phase 1 ClinicalTrials
Choroidal Neovascularization; Macular Degeneration; Neovascularization, Pathologic Phase 2 ClinicalTrials
CONTENTS